Annual long term liabilities:
$4.24M-$1.65M(-28.03%)Summary
- As of today (June 17, 2025), NAGE annual total long term liabilities is $4.24 million, with the most recent change of -$1.65 million (-28.03%) on December 1, 2024.
- During the last 3 years, NAGE annual long term liabilities has fallen by -$4.26 million (-50.16%).
- NAGE annual long term liabilities is now -50.16% below its all-time high of $8.50 million, reached on December 1, 2021.
Performance
NAGE Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$5.16M+$919.00K(+21.69%)Summary
- As of today (June 17, 2025), NAGE quarterly total long term liabilities is $5.16 million, with the most recent change of +$919.00 thousand (+21.69%) on March 1, 2025.
- Over the past year, NAGE quarterly long term liabilities has dropped by -$521.00 thousand (-9.18%).
- NAGE quarterly long term liabilities is now -39.35% below its all-time high of $8.50 million, reached on December 1, 2021.
Performance
NAGE quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NAGE Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -28.0% | -9.2% |
3 y3 years | -50.2% | -38.3% |
5 y5 years | -10.6% | +12.2% |
NAGE Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -50.2% | at low | -36.4% | +21.7% |
5 y | 5-year | -50.2% | at low | -39.4% | +21.7% |
alltime | all time | -50.2% | +1525.5% | -39.4% | >+9999.0% |
NAGE Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $5.16M(+21.7%) |
Dec 2024 | $4.24M(-28.0%) | $4.24M(-4.9%) |
Sep 2024 | - | $4.45M(-18.3%) |
Jun 2024 | - | $5.45M(-4.0%) |
Mar 2024 | - | $5.68M(-3.6%) |
Dec 2023 | $5.89M(-21.7%) | $5.89M(-12.6%) |
Sep 2023 | - | $6.73M(-3.3%) |
Jun 2023 | - | $6.96M(-5.0%) |
Mar 2023 | - | $7.33M(-2.5%) |
Dec 2022 | $7.52M(-11.6%) | $7.52M(-5.0%) |
Sep 2022 | - | $7.92M(-2.4%) |
Jun 2022 | - | $8.11M(-3.0%) |
Mar 2022 | - | $8.36M(-1.7%) |
Dec 2021 | $8.50M(+55.7%) | $8.50M(+17.5%) |
Sep 2021 | - | $7.23M(-3.2%) |
Jun 2021 | - | $7.47M(+38.2%) |
Mar 2021 | - | $5.41M(-1.0%) |
Dec 2020 | $5.46M(+15.2%) | $5.46M(+11.1%) |
Sep 2020 | - | $4.91M(+12.5%) |
Jun 2020 | - | $4.37M(-4.9%) |
Mar 2020 | - | $4.60M(-3.0%) |
Dec 2019 | $4.74M(+671.8%) | $4.74M(-4.7%) |
Sep 2019 | - | $4.97M(-4.1%) |
Jun 2019 | - | $5.19M(-4.0%) |
Mar 2019 | - | $5.40M(+779.6%) |
Dec 2018 | $614.00K(-23.4%) | $614.00K(-7.0%) |
Sep 2018 | - | $660.00K(-7.3%) |
Jun 2018 | - | $712.00K(+2.2%) |
Mar 2018 | - | $697.00K(-13.1%) |
Dec 2017 | $802.00K(-11.7%) | $802.00K(-6.1%) |
Sep 2017 | - | $854.50K(-9.2%) |
Jun 2017 | - | $940.70K(+0.7%) |
Mar 2017 | - | $934.30K(+2.8%) |
Dec 2016 | $908.60K | $908.60K(+65.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2016 | - | $550.20K(+1.2%) |
Jun 2016 | - | $543.70K(-84.0%) |
Mar 2016 | - | $3.40M(-12.6%) |
Dec 2015 | $3.89M(+53.2%) | $3.89M(-19.5%) |
Sep 2015 | - | $4.83M(-8.8%) |
Jun 2015 | - | $5.29M(+109.7%) |
Mar 2015 | - | $2.52M(-0.5%) |
Dec 2014 | $2.54M(+425.1%) | $2.54M(+313.5%) |
Sep 2014 | - | $613.70K(+5.9%) |
Jun 2014 | - | $579.60K(+31.4%) |
Mar 2014 | - | $441.00K(-8.8%) |
Dec 2013 | $483.30K(+73.7%) | $483.30K(+21.1%) |
Sep 2013 | - | $399.20K(+2.2%) |
Jun 2013 | - | $390.70K(+15.8%) |
Mar 2013 | - | $337.50K(+21.3%) |
Dec 2012 | $278.20K(-23.9%) | $278.20K(-7.6%) |
Sep 2012 | - | $301.00K(-11.1%) |
Jun 2012 | - | $338.40K(-9.7%) |
Mar 2012 | - | $374.70K(+2.5%) |
Dec 2011 | $365.60K(-15.4%) | $365.60K(+0.6%) |
Sep 2011 | - | $363.60K(-7.1%) |
Jun 2011 | - | $391.50K(-6.3%) |
Mar 2011 | - | $417.90K(-3.2%) |
Dec 2010 | $431.90K(+30.8%) | $431.90K(-17.3%) |
Sep 2010 | - | $522.20K(-5.2%) |
Jun 2010 | - | $550.70K(-4.4%) |
Mar 2010 | - | $576.10K(+74.5%) |
Dec 2009 | $330.20K(+26.7%) | $330.20K(+45.5%) |
Sep 2009 | - | $227.00K(-3.2%) |
Jun 2009 | - | $234.50K(-4.4%) |
Mar 2009 | - | $245.30K(-5.9%) |
Dec 2008 | $260.60K | $260.60K(+12.0%) |
Sep 2008 | - | $232.70K(-10.4%) |
Jun 2008 | - | $259.70K(>+9900.0%) |
Feb 2007 | - | $0.00 |
FAQ
- What is Niagen Bioscience annual total long term liabilities?
- What is the all time high annual long term liabilities for Niagen Bioscience?
- What is Niagen Bioscience annual long term liabilities year-on-year change?
- What is Niagen Bioscience quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Niagen Bioscience?
- What is Niagen Bioscience quarterly long term liabilities year-on-year change?
What is Niagen Bioscience annual total long term liabilities?
The current annual long term liabilities of NAGE is $4.24M
What is the all time high annual long term liabilities for Niagen Bioscience?
Niagen Bioscience all-time high annual total long term liabilities is $8.50M
What is Niagen Bioscience annual long term liabilities year-on-year change?
Over the past year, NAGE annual total long term liabilities has changed by -$1.65M (-28.03%)
What is Niagen Bioscience quarterly total long term liabilities?
The current quarterly long term liabilities of NAGE is $5.16M
What is the all time high quarterly long term liabilities for Niagen Bioscience?
Niagen Bioscience all-time high quarterly total long term liabilities is $8.50M
What is Niagen Bioscience quarterly long term liabilities year-on-year change?
Over the past year, NAGE quarterly total long term liabilities has changed by -$521.00K (-9.18%)